Abstract:Quantifying individualized deviations in the brain structure of patients with brain disorders from those of normal individuals is crucial for understanding disease pathology and guiding personalized management. In this study, we aimed to establish Chinese-specific normative references using 3D T1-weighted magnetic resonance images of 12,060 healthy controls (HCs) and to quantify the deviations in brain structure of 3,245 patients with multiple neurological diseases, including neurodegenerative diseases (mild cognitive impairment [n = 212], Alzheimer's disease [n = 467], and Parkinson's disease [PD, n = 1,263]), cerebrovascular disease (cerebral small vessel disease [n = 498]), and neuroinflammatory diseases (multiple sclerosis [MS, n = 497] and aquaporin-4 antibody-seropositive neuromyelitis optica spectrum disorder [NMOSD, n = 308]). The Chinese normative references exhibited a later peak age than those of previously reported references, which were mainly from European and North American populations, differing by 2.3 to 9.9 years. Distinct deviations in brain structural measures were observed among individuals with neurogenerative, cerebrovascular, and neuroinflammatory diseases. We subsequently performed three clinical tasks to assess the utility of individualized deviation scores. Task 1: We estimated the individual disease propensity score relative to that of HCs, with median scores ranging from 0.84 to 0.95. Task 2: We predicted the cognitive and physical scores of individuals with neurological diseases using cross-sectional data. The correlations between the predicted and actual scores ranged from 0.13 to 0.70. Task 3: In a longitudinal cohort, we analyzed the effects of different treatments on individuals with PD. Predictions of motor outcomes in PD patients receiving medication and deep brain stimulation showed correlations between predicted and actual variables ranging from 0.16 to 0.31. In addition, we stratified individuals with MS and NMOSD according to the predicted risks of disability progression. Comparative analyses demonstrated that deviation scores outperformed raw brain structural measures in disease propensity score estimation and risk stratification of neuroinflammatory patients. Longitudinal and sensitivity analyses confirmed the stability and robustness of deviation scores in individualized brain structure quantification. Finally, using these deviation scores, we created a clinically applicable individualized brain health report. In conclusion, the quantified individualized deviation scores derived from population-specific normative references can serve as a novel approach to understanding disease pathology and contribute to accurately personalized diagnosis and prognosis for various neurological diseases.

Capturing the individual deviations from normative models of brain structure for depressive diagnosis and treatment

Capturing the Individual Deviations from Normative Models of Brain Structure for Depression Diagnosis and Treatment.

Understanding the heterogeneity of dynamic functional connectivity patterns in first-episode drug naive depression using normative models

Parsing altered gray matter morphology of depression using a framework integrating the normative model and non-negative matrix factorization

Quantifying Individualized Deviations of Brain Structure in Patients with Multiple Neurological Diseases from Normative References

Individual deviations from normative electroencephalographic connectivity predict antidepressant response

Identifying Subgroups of Major Depressive Disorder Using Brain Structural Covariance Networks and Mapping of Associated Clinical and Cognitive Variables

Changes of brain morphometry in first-episode, drug-naïve, non-late-life adult patients with major depression: an optimized voxel-based morphometry study.

Twenty-Five Cohorts of Major Depressive Disorder in China: Evidence for Reduced But Not Enhanced Default Mode Network Functional Connectivity

Biotypes of major depressive disorder: Neuroimaging evidence from resting-state default mode network patterns.

Diagnosis of Major Depressive Disorder Based on Individualized Brain Functional and Structural Connectivity

More Alike than Different: Quantifying Deviations of Brain Structure and Function in Major Depressive Disorder across Neuroimaging Modalities

Structural Neuroimaging and Molecular Signatures of Drug‐Naive Depression With Melancholic Features

Convergent molecular and structural neuroimaging signatures of first-episode depression

Connectome Analysis of Functional and Structural Hemispheric Brain Networks in Major Depressive Disorder

Shared Differential Factors Underlying Individual Spontaneous Neural Activity Abnormalities in Major Depressive Disorder.

Using normative modeling to assess pharmacological treatment effect on brain state in patients with schizophrenia

Mapping Neurophysiological Subtypes of Major Depressive Disorder Using Normative Models of the Functional Connectome

Identifying two distinct neuroanatomical subtypes of first-episode depression using heterogeneity through discriminative analysis

Structural alterations as a predictor of depression – a 7-Tesla MRI-based multidimensional approach

Large Individual Differences in Functional Connectivity in the Context of Major Depression and Antidepressant Pharmacotherapy